October 23, 2025

Youth Nicotine Pouch Use Nearly Doubled, Study Shows

FDA authorizes 20 pouches in 2025; youth use rises; oral effects evidence remains limited.

Conexiant

October 22, 2025

FDA Redefining Depression Treatment with New Approvals?

Researchers analyze FDA-approved and Phase 3 antidepressants from 2009 to 2025.

Conexiant

October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 14, 2025

Global Drug Crisis Deepened Across Decades

A major global study tracked 30 years of drug use disorder trends across 204 countries.

Conexiant

October 14, 2025

Which ADHD Subtype Causes Most Harm?

Standardized interviews and scales in a university hospital program detail adult attention-deficit/hyperactivity disorder severity, function, and disability.

Conexiant

October 01, 2025

FDA Data Show Rise During Benadryl Social Media Challenge

TikTok trend resurfaces as diphenhydramine misuse among youth patients remains reported.

Conexiant

January 06, 2025

Alcohol Hepatitis: Why Females Face Higher Risks

Study reveals rising hepatitis rates in young adults, with females facing greater risks of cirrhosis and liver-related death.

Conexiant

September 25, 2025

GLP-1 RAs Show Lower Risks in Psoriasis

GLP-1 RAs use in psoriasis is associated with lower alcohol and substance abuse risks.

Conexiant

July 23, 2024

Study Examines Effects of Prenatal Cannabis Use

"As we continue to learn about the potential harms and benefits of prenatal cannabis use, clinicians must provide coordinated, nonstigmatizing care and education to support pregnant individuals in making informed decisions about cannabis use," noted study authors.

Conexiant